Repurposing pentoxifylline for the treatment of fibrosis: an overview
Fibrosis is a potentially debilitating disease with high morbidity rates. It is estimated that half of all deaths that occur in the USA are attributed to fibrotic disorders. Fibrotic disorders are characterized primarily by disruption in the extracellular matrix deposition and breakdown equilibrium,...
المؤلفون الرئيسيون: | Wen, W, Lee, S, Siang, R, Koh, R |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Springer Nature
2017
|
مواد مشابهة
-
Pentoxifylline in patients with oral submucous fibrosis
حسب: Ashwini Deshpande, وآخرون
منشور في: (2015-01-01) -
Efficacy of pentoxifylline in the management of oral submucous fibrosis
حسب: Santosh Patil, وآخرون
منشور في: (2014-01-01) -
Pentoxifylline Inhibits Pulmonary Fibrosis by Regulating Cellular Senescence in Mice
حسب: Yifan Lin, وآخرون
منشور في: (2022-05-01) -
Pentoxifylline in the Treatment of Acute Alcoholic Hepatitis
حسب: Arun S, وآخرون
منشور في: (2014-07-01) -
Pentoxifylline: An Immunomodulatory Drug for the Treatment of COVID-19
حسب: Hiren A. Dhameliya, وآخرون
منشور في: (2020-05-01)